Overview of the measurements
Time point | Baseline (T0) | 6 weeks (T1) | 6 months (T2) | 1 year (T3) | 2 years (T4) |
Measurement | |||||
PRIMARY OUTCOME | |||||
MRI of knee | X | X | |||
| |||||
SECONDARY OUTCOMES | |||||
Questionnaire + physical examination | X | X | |||
| |||||
MRI of knee | X | X | |||
| |||||
Radiograph of hands | X | X | |||
| |||||
OTHER VARIABLES | |||||
Questionnaires | X | X | X | X | X |
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
Physical examination | X | X | |||
| |||||
| |||||
| |||||
| |||||
| |||||
Blood measurements | X | X | X | X | X |
| |||||
| |||||
| |||||
| |||||
Photograph of hands | X | X | X | X | X |
| |||||
Dual energy X-ray absorptiometry scan | X | X | |||
| |||||
| |||||
| |||||
| |||||
Ultrasound Tissue Characterisation of Achilles tendon | X | X | |||
|
*Glucose, low-density lipoprotein, high-density lipoprotein, total cholesterol, triglyceride, estradiol, testosterone, androstenedione and 17-hydroxyprogesterone.
ACR, American College of Rheumatology; AP, anterior to posterior; AUSCAN, Australian Canadian Osteoarthritis Hand Index; BMD, bone mineral density; KOOS, Knee injury and Osteoarthritis Outcome Score; MOAKS, MRI Osteoarthritis Knee Score; MRS, Menopause Rating Scale; OA, osteoarthritis; OARSI, Osteoarthritis Research Society International; PPT, pain pressure threshold; SQUASH, Short Questionnaire to Assess Health-enhancing physical activity; TBS, Trabecular Bone Score.